{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:55:52Z","timestamp":1769100952084,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pfizer (Thailand) Ltd."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.hlc.2019.02.187","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T14:20:25Z","timestamp":1553696425000},"page":"390-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation"],"prefix":"10.1016","volume":"29","author":[{"given":"Piyameth","family":"Dilokthornsakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surakit","family":"Nathisuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rungroj","family":"Krittayaphong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurauma","family":"Chutinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-2789","authenticated-orcid":false,"given":"Unchalee","family":"Permsuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2019.02.187_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gheart.2014.01.004","article-title":"Global burden of atrial fibrillation in developed and developing nations","volume":"9","author":"Chugh","year":"2014","journal-title":"Glob Heart"},{"key":"10.1016\/j.hlc.2019.02.187_bib0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2019.02.187_bib0015","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2019.02.187_bib0020","series-title":"Thai guideline for diagnosis and treatment of atrial fibrillation","author":"Sithitsook","year":"2012"},{"key":"10.1016\/j.hlc.2019.02.187_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11096-011-9597-8","article-title":"Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand","volume":"34","author":"Saokaew","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.hlc.2019.02.187_bib0030","first-page":"1274","article-title":"Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand","volume":"97","author":"Methavigul","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hlc.2019.02.187_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21090","article-title":"Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis","volume":"21","author":"Sterne","year":"2017","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.hlc.2019.02.187_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2015.11.084","article-title":"Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups","volume":"204","author":"Lip","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1389","key":"10.1016\/j.hlc.2019.02.187_bib0045","first-page":"94 e4","article-title":"Cost-utility analysis of oral anticoagulants for nonvalvular atrial fibrillation patients at the police general hospital, Bangkok, Thailand","volume":"36","author":"Jarungsuccess","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.hlc.2019.02.187_bib0050","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCOUTCOMES.113.000661","article-title":"Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation","volume":"6","author":"Canestaro","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hlc.2019.02.187_bib0055","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","article-title":"Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation","volume":"44","author":"Harrington","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.hlc.2019.02.187_bib0060","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/heartjnl-2011-300646","article-title":"Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation","volume":"98","author":"Kansal","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2019.02.187_bib0065","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.STR.19.12.1497","article-title":"Recovery of motor function after stroke","volume":"19","author":"Bonita","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.hlc.2019.02.187_bib0070","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2019.02.187_bib0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2019.02.187_bib0080","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2019.02.187_bib0085","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2019.02.187_bib0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jocn.2014.08.031","article-title":"National data on stroke outcomes in Thailand","volume":"22","author":"Kongbunkiat","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.hlc.2019.02.187_bib0095","first-page":"508","article-title":"Thai Registry in Acute Coronary Syndrome (TRACS) \u2014 an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year","volume":"95","author":"Srimahachota","year":"2012","journal-title":"J Med Assoc Thai"},{"issue":"Suppl. 7","key":"10.1016\/j.hlc.2019.02.187_bib0100","first-page":"S190","article-title":"Hospitalized incidence and outcomes of upper gastrointestinal bleeding in Thailand","volume":"95","author":"Sangchan","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hlc.2019.02.187_bib0105","series-title":"Public Health Statistics 2014","author":"Strategy and Planning Division Ministry of Public Health","year":"2015"},{"key":"10.1016\/j.hlc.2019.02.187_bib0110","series-title":"Rate of exchange of commercial banks","author":"Bank of Thailand","year":"2018"},{"key":"10.1016\/j.hlc.2019.02.187_bib0115","series-title":"Consumer price index","author":"Division of Trade Information and Econoimc Indices Ministry of Commerce","year":"2018"},{"issue":"Suppl. 5","key":"10.1016\/j.hlc.2019.02.187_bib0120","first-page":"S50","article-title":"Handling time in economic evaluation studies","volume":"97","author":"Permsuwan","year":"2014","journal-title":"J Med Assoc Thai"},{"issue":"Suppl. 2","key":"10.1016\/j.hlc.2019.02.187_bib0125","first-page":"S53","article-title":"Handling time in economic evaluation studies","volume":"91","author":"Permsuwan","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hlc.2019.02.187_bib0130","first-page":"132","article-title":"Costs of lifetime treatment of acure coronary syndrome at Ramathibodi hospital","volume":"19","author":"Anukoolsawat","year":"2006","journal-title":"Thai Heart J"},{"key":"10.1016\/j.hlc.2019.02.187_bib0135","first-page":"1266","article-title":"Cost of acute and sub-acute care for stroke patients","volume":"95","author":"Khiaocharoen","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hlc.2019.02.187_bib0140","first-page":"15","article-title":"Cost-effectiveness analysis of celecoxib on an avoidance of gastrointestianl adverse events in pateints with osteoarthritis","volume":"1","author":"Limwattananon","year":"2005","journal-title":"Isan J Pharm Sci"},{"key":"10.1016\/j.hlc.2019.02.187_bib0145","first-page":"1257","article-title":"Unit cost of stroke rehabilitation","volume":"91","author":"Archongka","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hlc.2019.02.187_bib0150","series-title":"Cost-effectiveness of PT-INR monitoring with point-of-care for dosage adjusment and adverse event in patients receiving warfarin","author":"Santiwongchai","year":"2014"},{"issue":"Suppl. 5","key":"10.1016\/j.hlc.2019.02.187_bib0155","first-page":"S127","article-title":"Standard cost lists for health economic evaluation in Thailand","volume":"97","author":"Riewpaiboon","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hlc.2019.02.187_bib0160","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.socscimed.2009.05.033","article-title":"Economic valuation of informal care in Asia: a case study of care for disabled stroke survivors in Thailand","volume":"69","author":"Riewpaiboon","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.hlc.2019.02.187_bib0165","series-title":"Median drug price annoucement","author":"National Drug System Development Committee","year":"2017"},{"key":"10.1016\/j.hlc.2019.02.187_bib0170","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11136-010-9591-y","article-title":"Factors determining utility measured with the EQ-5D in patients with atrial fibrillation","volume":"19","author":"Berg","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.hlc.2019.02.187_bib0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.STR.0000196990.69412.fb","article-title":"Long-term outcome after stroke: evaluating health-related quality of life using utility measurements","volume":"37","author":"Haacke","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.hlc.2019.02.187_bib0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2796.1999.00531.x","article-title":"Quality of life after cerebrovascular stroke: a systematic study of patients\u2019 preferences for different functional outcomes","volume":"246","author":"Hallan","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.hlc.2019.02.187_bib0185","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jech.57.8.622","article-title":"Continuing inequality: gender and social class influences on self perceived health after a heart attack","volume":"57","author":"Lacey","year":"2003","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.hlc.2019.02.187_bib0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jamia.1997.0040049","article-title":"Automated computer interviews to elicit utilities: potential applications in the treatment of deep venous thrombosis","volume":"4","author":"Lenert","year":"1997","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.hlc.2019.02.187_bib0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1258\/1355819011927288","article-title":"How patients with atrial fibrillation value different health outcomes: a standard gamble study","volume":"6","author":"Robinson","year":"2001","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.hlc.2019.02.187_bib0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0272989X06290495","article-title":"Preference-Based EQ-5D index scores for chronic conditions in the United States","volume":"26","author":"Sullivan","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.hlc.2019.02.187_bib0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CEOR.S38062","article-title":"Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?","volume":"5","author":"Thavorncharoensap","year":"2013","journal-title":"Clin Outcomes Res"},{"key":"10.1016\/j.hlc.2019.02.187_bib0210","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.1995.03530230025025","article-title":"Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation","volume":"274","author":"Gage","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2019.02.187_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40261-013-0144-3","article-title":"Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis","volume":"34","author":"Rognoni","year":"2014","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.hlc.2019.02.187_bib0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clinthera.2013.12.011","article-title":"Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation","volume":"36","author":"Lip","year":"2014","journal-title":"Clin Ther"},{"issue":"Suppl. 5","key":"10.1016\/j.hlc.2019.02.187_bib0225","first-page":"S27","article-title":"Measurement of health outcomes","volume":"97","author":"Thavorncharoensap","year":"2014","journal-title":"J Med Assoc Thai"},{"issue":"Suppl. 5","key":"10.1016\/j.hlc.2019.02.187_bib0230","first-page":"S4","article-title":"Guidelines for health technology assessment in Thailand (second edition) \u2014 the development process","volume":"97","author":"Chaikledkaew","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hlc.2019.02.187_bib0235","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.thromres.2013.08.019","article-title":"Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand","volume":"132","author":"Saokaew","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.hlc.2019.02.187_bib0240","series-title":"Thailand: WHO statistical profile","author":"World Health Orgainzation","year":"2015"},{"key":"10.1016\/j.hlc.2019.02.187_bib0245","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","article-title":"The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life","volume":"156","author":"Gage","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hlc.2019.02.187_bib0250","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.293.6.699","article-title":"Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation","volume":"293","author":"O\u2019Brien","year":"2005","journal-title":"JAMA"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395061930263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395061930263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:59:53Z","timestamp":1761415193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S144395061930263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S144395061930263X"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2019.02.187","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2019.02.187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}